Drug Profile
Research programme: BACE1 protein inhibitors - Bristol-Myers Squibb
Alternative Names: BMS 782450Latest Information Update: 12 Nov 2013
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Small molecules
- Mechanism of Action BACE1 protein inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 07 Nov 2013 Discontinued - Preclinical for Alzheimer's disease in USA (unspecified route)
- 18 Apr 2007 Preclinical trials in Alzheimer's disease in USA (unspecified route)